Sylwia Kopeć

Sylwia Kopeć

Auto-generated profile, based on publicly available information

Sylwia Kopeć

Department of Oncology, Lower Silesian Centre of Oncology, Pulmonology and Haematology, Wrocław, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KDKlaudia Drewko
Klaudia Drewko
SKSylwia Kopeć
Sylwia Kopeć
MOMateusz Orłowski
Mateusz Orłowski
JKJulia Kuźniar
Julia Kuźniar
PKPatrycja Kozubek
Patrycja Kozubek
Introduction and purpose: There has been a global increase in the prevalence of adults diagnosed with primary brain tumors. Meningiomas are the most common primary brain tumors, the majority are benign. For asymptomatic, slow-growing tumors, observation with imaging studies may be considered. Surgical resection is the main form of treatment. Other options are radiotherapy and chemotherapy. Astrocytomas are biologically and morphologically diverse group of brain tumors divided into two classes. IDH-wild-type tumors are classified as grade IV astrocytomas. They are widespread malignant brain tumors in adults. Despite aggressive therapy consisting of surgical resection, radiotherapy and temozolomide as many as 90% of grade IV gliomas will have a local recurrence. Ependymoma is a primary tumor. The most proper method of treatment is GTR, in addition radiotherapy is considered helpful. Material and Methods: Bibliographic research was limited to papers published between 2014 and 2024. We have analyzed articles with free and paid access. The articles were identified using the PubMed and Google Scholar search, using key terms. Results: The paper focuses on efficacy and prognosis of selected therapies for cancers of the central nervous system with varying degrees of malignancy. This study reviews the prevalence, current diagnostic tools and evidence-based methods. Conclusions: Brain tumor treatment depends on the type of tumor and the patient's condition. Meningiomas can be treated from observation to surgical removal, and if the tumor cannot be completely removed, radiotherapy is used. Low-grade gliomas are treated surgically, while high-grade gliomas require additional chemotherapy and radiotherapy. Modern surgical techniques and stereotactic radiosurgery (SRS) improve treatment results. Ependymoma, a rare CNS tumor, requires complete removal in the case of benign changes, and radiotherapy in the case of higher-grade tumors.

21 July 2026 in Aktualności Neurologiczne
Verified
Journal Article
Open access
PDF file
MNMarta Nowakowska-Kotas
Marta Nowakowska-Kotas
SKSylwia Kopeć
Sylwia Kopeć
KDKlaudia Drewko
Klaudia Drewko
PKPatrycja Kozubek
Patrycja Kozubek
MOMateusz Orłowski
Mateusz Orłowski
SBSławomir Budrewicz
Sławomir Budrewicz
Oncological treatment is becoming increasingly effective, but also more complex, and is associated with serious side effects that may affect the nervous system. The article aims to highlight and summarise the complications related to the most common treatment modalities for ovarian, lung, and breast cancers. A comprehensive search was conducted using the PubMed, Scopus, and Web of Science databases, to identify English-language articles in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) recommendations. A total of 78 articles were included in the analysis. In ovarian cancer, surgery was found to be associated with complications such as stroke and delirium. Adjuvant chemotherapy mainly includes platinum compounds (carboplatin or cisplatin) and taxanes (paclitaxel or docetaxel), which commonly induce neuropathy. Neoadjuvant chemotherapy, including poly (ADP-ribose) polymerase (PARP) inhibitors, causes relatively mild neurological complications such as headache and insomnia. Radiotherapy for lung cancers may result in headache, nausea, vomiting, drowsiness, fatigue, cognitive impairment, and leukoencephalopathy or radiation necrosis of the spinal cord. Platinum compounds and taxanes cause chemotherapy-induced peripheral neuropathy, whereas PD-1 inhibitors may lead to immune-related neurological toxicity. The main complications of breast cancer therapy include chemotherapy-induced peripheral neuropathy, cognitive impairment, stroke, encephalopathy, chronic pain, and brachial plexopathy. Many mechanisms underlying neurotoxicity have not yet been fully elucidated, and knowledge regarding the short- and long-term complications affecting the nervous system still requires further development.

16 July 2024 in Environmental Medicine
Verified
Journal Article
Open access
PKPatrycja Kozubek
Patrycja Kozubek
SKSylwia Kopeć
Sylwia Kopeć
KDKlaudia Drewko
Klaudia Drewko
JKJulia Kuźniar
Julia Kuźniar
MOMateusz Orłowski
Mateusz Orłowski
KGKrzysztof Gomułka
Krzysztof Gomułka
Introduction and objective: Drug hypersensitivity reactions are common in the therapy of various diseases. The Gell and Coombs classification divides immunologic drug hypersensitivity reactions into four major pathophysiologic categories based on immunologic mechanism (I, II, III, IV). The...

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KDKlaudia Drewko
Klaudia Drewko
SKSylwia Kopeć
Sylwia Kopeć
KBKarolina Bryła
Karolina Bryła
SGSzymon Gruszka
Szymon Gruszka
KKKlaudia Kożuchowska
Klaudia Kożuchowska
DPDawid Pilarz
Dawid Pilarz
Introduction: In recent years, the rise in population aging and longer life expectancy have led to a higher prevalence of Alzheimer’s disease (AD), making it the most widespread form of dementia globally. Despite, the disease being mainly associated with cognitive decline and severe memory loss, there are many behavioral and psychological symptoms of Alzheimer’s disease that prevent independent functioning. This introduction highlights the significance of understanding neuropsychiatric symptoms that appear in individuals with Alzheimer’s disease which can be very diverse. Brief description of the state of knowledge: Patients with Alzheimer’s disease suffer from a broad spectrum of neuropsychiatric symptoms including depression, aggression, apathy, delusions/hallucinations, abnormal motor behavior, unusual activities, eating disorders, changes in biological rhythms, and sexual dysfunctions. The majority of these symptoms appear in over half of the patients with Alzheimer’s disease, posing a serious concern that often leads to hospitalization. Despite the considerable social impact, treatment approaches for these symptoms remain poorly defined. Additionally, the presentation and severity of these symptoms can vary depending on the patient’s gender and age of onset. Summary: In summary, the aim of this review is to outline and highlight the latest knowledge on neuropsychiatric disorders, which occur in patients suffering from Alzheimer’s disease, focusing mainly on mood and behavioral symptoms. These symptoms can be classified into various categories based on specific criteria, but what matters most is accurately identifying the disease’s signs, as they can sometimes appear before the more typical symptoms of Alzheimer’s disease.